Bartizal Ken 4
4 · Trius Therapeutics Inc · Filed Nov 18, 2011
Insider Transaction Report
Form 4
Bartizal Ken
Chief Development Officer
Transactions
- Sale
Common Stock
2011-11-17$7.85/sh−1,687$13,243→ 109,844 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2011.
- [F2]Includes 4,654 and 7,168 shares of Common Stock that were acquired by the Reporting Person on 11/19/10 and 5/20/11, respectively, pursuant to the Issuer's Employee Stock Purchase Plan.